Does Phaster Mean Better?(Editorial) Does Phaster Mean Better?(Editorial)

Does Phaster Mean Better?(Editorial‪)‬

Clinical Chemistry 1997, March, 43, 3

    • 2,99 €
    • 2,99 €

Descripción editorial

The accelerated pace of discovery of disease-causing genes has made efficient mutation detection a priority. Identification of DNA sequence variants allows human geneticists to determine, among other things, whether a candidate gene contributes to disease susceptibility, to identify new alleles at known loci, and to develop molecular diagnostic tests. Once a susceptibility gene has been identified, the investigator interested in molecular diagnostics or genotype-phenotype correlation must decide how to perform rapid, sensitive detection of mutations. Grompe [1] divided these techniques into those that are most useful for identifying known mutations and those that are better for detecting novel mutations. However, he also allowed that no one method would be appropriate for all situations. Clearly, the choices investigators make will be based, in part, on what they are trying to accomplish (e.g., diagnostics vs population studies of allele frequencies); the goal will also dictate the level of sensitivity required and, conversely, the proportion of false positives or negatives that can be tolerated. Other factors such as knowledge of genomic size, sequence, and structure; availability of RNA/cDNA; and access to equipment and technical expertise will also influence the decision.

GÉNERO
Ciencia y naturaleza
PUBLICADO
1997
1 de marzo
IDIOMA
EN
Inglés
EXTENSIÓN
11
Páginas
EDITORIAL
American Association for Clinical Chemistry, Inc.
INFORMACIÓN DEL PROVEEDOR
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
TAMAÑO
152,7
KB
Celiac Disease and IGA Deficiency: Complications of Serological Testing Approaches Encountered in the Clinic (Evidence-Based Laboratory Medicine and Test Utilization) (Clinical Report) Celiac Disease and IGA Deficiency: Complications of Serological Testing Approaches Encountered in the Clinic (Evidence-Based Laboratory Medicine and Test Utilization) (Clinical Report)
2008
None of Four Commercially Available Assays Detects Prolactin in Human Saliva (Technical Briefs) None of Four Commercially Available Assays Detects Prolactin in Human Saliva (Technical Briefs)
2000
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs) Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs) Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005